Advertisement
Screener

INTERLEUKIN GENETICS INC Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent

INTERLEUKIN GENETICS INC Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent

INTERLEUKIN GENETICS INC reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$5.12 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.

Discontinued › Income Statement › Net Income

us-gaap:IncomeLossFromContinuingOperations · last filed 2013-03-28

  • INTERLEUKIN GENETICS INC income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2012-12-31 was -$1.19M.
  • INTERLEUKIN GENETICS INC income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2012-09-30 was -$1.29M.
  • INTERLEUKIN GENETICS INC income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2012-06-30 was -$1.23M.
  • INTERLEUKIN GENETICS INC income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2012-03-31 was -$1.41M.
  • INTERLEUKIN GENETICS INC income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2012 was -$5.12M.
  • INTERLEUKIN GENETICS INC income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2011 was -$5.18M.
  • INTERLEUKIN GENETICS INC income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2010 was -$6.47M.
Period endIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 monthIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 monthIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 9 monthIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month
2012-12-31-$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
-$2.48M
derived: sum of 2 quarters · filed 2013-03-28
-$3.71M
derived: sum of 3 quarters · filed 2013-03-28
-$5.12M
10-K · filed 2013-03-28
2012-09-30-$1.29M
10-Q · filed 2012-11-14
-$2.52M
derived: sum of 2 quarters · filed 2012-11-14
-$3.93M
10-Q · filed 2012-11-14
-$5.35M
derived: sum of 4 quarters · filed 2013-03-28
2012-06-30-$1.23M
10-Q · filed 2012-08-14
-$2.64M
10-Q · filed 2012-08-14
-$4.07M
derived: sum of 3 quarters · filed 2013-03-28
-$5.20M
derived: sum of 4 quarters · filed 2013-03-28
2012-03-31-$1.41M
derived: 10-K 12 month − 3 quarters · filed 2013-03-28
-$2.84M
derived: sum of 2 quarters · filed 2013-03-28
-$3.97M
derived: sum of 3 quarters · filed 2013-03-28
-$5.34M
derived: sum of 4 quarters · filed 2013-03-28
2011-12-31-$1.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
-$2.56M
derived: sum of 2 quarters · filed 2013-03-28
-$3.93M
derived: sum of 3 quarters · filed 2013-03-28
-$5.18M
10-K · filed 2013-03-28
2011-09-30-$1.13M
10-Q · filed 2012-11-14
-$2.51M
derived: sum of 2 quarters · filed 2012-11-14
-$3.76M
10-Q · filed 2012-11-14
2011-06-30-$1.37M
10-Q · filed 2012-08-14
-$2.63M
10-Q · filed 2012-08-14
2010-12-31-$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
-$2.61M
derived: sum of 2 quarters · filed 2012-03-29
-$4.49M
derived: sum of 3 quarters · filed 2012-03-29
-$6.47M
10-K · filed 2012-03-29
2010-09-30-$1.44M
10-Q · filed 2011-11-10
-$3.32M
derived: sum of 2 quarters · filed 2011-11-10
-$5.30M
10-Q · filed 2011-11-10
2010-06-30-$1.88M
10-Q · filed 2011-08-12
-$3.86M
10-Q · filed 2011-08-12